Results 221 to 230 of about 173,582 (279)

Roles of AFP, AFP-L3, DCP and GP73 in Diagnosis of Hepatocellular Carcinoma and Prediction of Recurrence in Patients. [PDF]

J Cancer
Liao Y, Mo Z, Ye C, Chen Y, Dong H, Hu B.   +5 more
europepmc   +1 more source

Predictors of True Early Recurrence in Patients Undergoing Radiofrequency Ablation for Hepatocellular Carcinoma

JGH Open, Volume 10, Issue 4, April 2026.
ABSTRACT Aims To analyze risk factors of true early recurrence in patients undergoing radiofrequency ablation (RFA) for early‐stage hepatocellular carcinoma (HCC). Methods and Results We enrolled 791 patients with newly diagnosed early‐stage HCC (i.e., within Milan criteria) and Child–Pugh class A liver disease undergoing percutaneous RFA.
Yi‐Hao Yen, Kwong‐Ming Kee, Chao‐Hung Hung, Chien‐Hung Chen, Tsung‐Hui Hu, Jing‐Houng Wang, Sheng‐Nan Lu   +6 more
wiley   +1 more source

Gd-EOB-DTPA MRI radiomics-clinical nomogram for preoperatively predicting dual-positive Ki-67/MVI status in hepatocellular carcinoma: A retrospective study. [PDF]

Medicine (Baltimore)
Yu H, Kong D, Mo X, Wu J, Wu J, Wang P.
europepmc   +1 more source

Usefulness of Gamma‐Glutamyl Transferase and Sequential Carbohydrate‐Deficient Transferrin for Unhealthy Alcohol Use Screening in Indigenous Communities

The Kaohsiung Journal of Medical Sciences, Volume 42, Issue 4, April 2026.
ABSTRACT Unhealthy alcohol use (UAU) screening facilitates identification of patients with alcohol use problems for intervention. This study evaluates the usefulness of gamma‐glutamyl transferase (GGT) and sequential percentage of carbohydrate‐deficient transferrin (%CDT) in community screening for UAU.
Jing‐Houng Wang, Hui‐Min Tien, Hsiao‐Chu Lien, Pei‐Lin Chou, Yu‐Ling Chen, Nien‐Tzu Hsu, Sheng‐Nan Lu   +6 more
wiley   +1 more source

An innovative chitosan-coated aquatic feed pellets production from coastal waste using top-spray fluidized bed drying. [PDF]

Sci Rep
Maikaew J, Srisang N, Tambunlertchai S, Srisang S.   +3 more
europepmc   +1 more source

Molecular Insights Into Canine Hepatocellular Carcinoma: A Cross‐Species Transcriptomic Comparison With Human HCC

Molecular Carcinogenesis, Volume 65, Issue 4, Page 523-536, April 2026.
ABSTRACT Canine hepatocellular carcinoma (HCC) requires further molecular characterization to identify diagnostic and therapeutic targets, and to establish whether dogs with this condition can model the human disease. Accordingly, we aimed to identify differentially expressed genes (DEGs) in canine HCC and evaluate cross‐species transcriptomic ...
Mohammad Arif, MD Nazmul Hasan, Nobuhiro Nozaki, Yutaro Ide, Yoshiyuki Akiyama, Shaohsu Wang, Most Shumi Akhter Shathi, Osamu Yamato, Naoki Miura   +8 more
wiley   +1 more source

Characteristics of Recurrent Hepatocellular Carcinoma Based on Serum AFP, PIVKA-II, and Genetic Mutations. [PDF]

Medicina (Kaunas)
Cho IS, Ahn KS, Jeong S, Kim TS, Kim MJ, Yang SK, Cho S, Kim YH.   +7 more
europepmc   +1 more source

AFP software launched

Reinforced Plastics, 2008
openaire   +1 more source

Clinical Trial: Early Nivolumab Addition to Regorafenib in Patients With Hepatocellular Carcinoma in Second‐Line (The GOING Trial)

Alimentary Pharmacology &Therapeutics, Volume 63, Issue 7, Page 955-966, April 2026.
In the phase I/IIa GOING trial, an add‐on strategy with regorafenib followed by nivolumab showed a manageable safety profile and meaningful clinical activity in second‐line hepatocellular carcinoma, with a median overall survival of 25 months and 45% three‐year survival in sorafenib‐experienced patients.
Marco Sanduzzi‐Zamparelli, Ana Matilla, José Luis Lledo, Sergio Muñoz‐Martínez, María Varela, Mercedes Iñarrairaegui, Christie Perelló, Beatriz Mínguez, Neus Llarch, Laura Márquez, Antonio Guerrero, Gemma Iserte, Andrés Castaño‐García, Laura Carrión, Marta Fortuny, Jordi Rimola, Ángeles García‐Criado, Gema Domenech, Ferran Torres, José Rios‐Guillermo, Loreto Boix, Esther Samper, Àngels Kateb, Jordi Bruix, Maria Reig   +24 more
wiley   +1 more source

Serum Extracellular Vesicle-Associated GULP1 Is a Key Indicator of Hepatocellular Carcinoma. [PDF]

Oncol Res
Kim HS, Son JA, Kang M, Kim SS, Baek GO, Yoon MG, Jang SH, Jung D, Han JE, Cheong JY, Eun JW.   +10 more
europepmc   +1 more source